Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autonomic dysreflexia.

A K Karlsson1

  • 1Spinal Injuries Unit, Institution of Clinical Neuroscience, University of Göteborg, Sweden.

Spinal Cord
|August 4, 1999
PubMed
Summary
This summary is machine-generated.

Autonomic dysreflexia (AD) is a serious condition in spinal cord injury (SCI) patients above T6. This review covers AD

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International spinal cord injury skin and thermoregulation function basic data set.

Spinal cord·2012
Same author

Early interdisciplinary rehabilitation programme for whiplash associated disorders.

Disability and rehabilitation·2001
Same author

Insulin resistance and sympathetic function in high spinal cord injury.

Spinal cord·1999
Same author

Regional sympathetic function in high spinal cord injury during mental stress and autonomic dysreflexia.

Brain : a journal of neurology·1998
Same author

Aural rehabilitation in the elderly: supply of hearing aids related to measured need and self-assessed hearing problems.

Scandinavian audiology·1998
Same author

Peripheral afferent stimulation of decentralized sympathetic neurons activates lipolysis in spinal cord-injured subjects.

Metabolism: clinical and experimental·1998
Same journal

The Early and Intensive Motor Training for Spinal Cord Injury Trial: key principles to consider when undertaking large international investigator-driven clinical trials.

Spinal cord·2026
Same journal

Factors related to reaching near full of predicted spinal cord injury life expectancy: A prospective cohort study.

Spinal cord·2026
Same journal

Radiologic factors in thoracolumbar burst fractures with versus without neurologic deficit: a systematic review and meta-analysis.

Spinal cord·2026
Same journal

Spinal cord shape factor as a predictor of postoperative functional outcome in thoracic ossification of the posterior longitudinal ligament.

Spinal cord·2026
Same journal

Impact of hypericin and Hypericum perforatum L. (St. John's Wort) extract on oxidative stress and neurotrophic factors during the acute phase of spinal cord injury in male rats.

Spinal cord·2026
Same journal

Glia cell-derived extracellular vesicles as modulators in spinal cord injury repair.

Spinal cord·2026
See all related articles

Area of Science:

  • Neurology
  • Physiology
  • Rehabilitation Medicine

Background:

  • Autonomic dysreflexia (AD) is a potentially life-threatening condition complicating spinal cord injury (SCI) above the T6 level.
  • New insights into pathogenic mechanisms and metabolic effects of AD are emerging.
  • Existing treatments focus on removing triggers, but new mechanisms and treatments are being explored.

Purpose of the Study:

  • To provide a comprehensive review of autonomic dysreflexia (AD) in spinal cord injury (SCI).
  • To discuss clinical aspects, pathogenic mechanisms, incidence, prevalence, and triggering factors of AD.
  • To explore current and future treatment strategies for AD.

Main Methods:

  • Literature review of clinical aspects, pathophysiology, epidemiology, and treatment of autonomic dysreflexia (AD).

Related Experiment Videos

  • Synthesis of recent data on pathogenic mechanisms and metabolic effects.
  • Discussion of symptomatic and specific treatment modalities.

    • Main Results:

    • AD is associated with significant morbidity, including cerebral hemorrhage, seizures, and pulmonary edema.
    • Triggers for AD are diverse and can be influenced by new treatments.
    • Pathophysiology and metabolic effects require further investigation.

    Conclusions:

    • A precise definition and deeper understanding of AD pathophysiology are needed.
    • Further research on incidence, prevalence, and novel therapeutic approaches is essential.
    • Effective management of AD requires addressing both known and emerging triggers and mechanisms.